These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11115958)

  • 1. Survival in children with perinatal HIV infection and very low CD4 lymphocyte counts.
    Hsu HW; Pelton S; Williamson JM; Thomas P; Mascola L; Ortiz I; Rakusan T; Melville S; Bertolli J
    J Acquir Immune Defic Syndr; 2000 Nov; 25(3):269-75. PubMed ID: 11115958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of human immunodeficiency virus 1-related disease among 512 infants born to infected women in New York City. The New York City Perinatal HIV Transmission Collaborative Study Group.
    Bamji M; Thea DM; Weedon J; Krasinski K; Matheson PB; Thomas P; Lambert G; Abrams EJ; Steketee R; Heagarty M
    Pediatr Infect Dis J; 1996 Oct; 15(10):891-8. PubMed ID: 8895922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections.
    Williams PL; Currier JS; Swindells S
    AIDS; 1999 Jun; 13(9):1035-44. PubMed ID: 10397533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the population of human immunodeficiency virus-infected children at risk for Mycobacterium avium-intracellulare infection.
    Lewis LL; Butler KM; Husson RN; Mueller BU; Fowler CL; Steinberg SM; Pizzo PA
    J Pediatr; 1992 Nov; 121(5 Pt 1):677-83. PubMed ID: 1432413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A retrospective cohort study on survival time of AIDS death cases receiving Antiretroviral Therapy and related factors].
    Hao L; Zhu X; Wang G; Lin B; Qian Y; Tao X; Hu J; Yang X; Kang D
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Jun; 48(6):466-70. PubMed ID: 25219434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4 percentage is an independent predictor of survival in patients starting antiretroviral therapy with absolute CD4 cell counts between 200 and 350 cells/microL.
    Moore DM; Hogg RS; Yip B; Craib K; Wood E; Montaner JS
    HIV Med; 2006 Sep; 7(6):383-8. PubMed ID: 16903983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of opportunistic disease on survival in patients with HIV infection.
    Chaisson RE; Gallant JE; Keruly JC; Moore RD
    AIDS; 1998 Jan; 12(1):29-33. PubMed ID: 9456252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the mortality and risk factors among HIV/AIDS patients receiving antiretroviral therapy in Xinjiang Uygur Autonomous Region].
    Ni M; Chen X; Hu X; Ma Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Nov; 48(11):953-8. PubMed ID: 25582364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
    Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
    JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
    Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
    Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
    Lazaro E; Coureau G; Guedj J; Blanco P; Pellegrin I; Commenges D; Dabis F; Moreau JF; Pellegrin JL; Thiébaut R;
    Antivir Ther; 2006; 11(3):343-50. PubMed ID: 16759051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk for preventable opportunistic infections in persons with AIDS after antiretroviral therapy increases CD4+ T lymphocyte counts above prophylaxis thresholds.
    Dworkin MS; Hanson DL; Kaplan JE; Jones JL; Ward JW
    J Infect Dis; 2000 Aug; 182(2):611-5. PubMed ID: 10915098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers.
    Bunders M; Thorne C; Newell ML;
    AIDS; 2005 Jul; 19(10):1071-9. PubMed ID: 15958839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sex specific mortality in HIV/AIDS patients receiving antiretroviral therapy and risk factors in Xinjiang Uygur autonomous region].
    Ni M; Chen X; Ma Y; Hu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Sep; 36(9):971-5. PubMed ID: 26814865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of immune survival factors in pediatric HIV-1 infection.
    Shearer WT; Easley KA; Goldfarb J; Jenson HB; Rosenblatt HM; Kovacs A; McIntosh K;
    Ann N Y Acad Sci; 2000 Nov; 918():298-312. PubMed ID: 11144332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.